Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
6.98
0.00
(0.00%)
At close: March 3 at 3:00:00 PM EST
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
-11,922
-11,922
-21,005
-21,362
-12,134
Investing Cash Flow
-613
-613
1,298
-316
-1,062
Financing Cash Flow
25,528
25,528
1,556
-800
47,917
End Cash Position
19,460
19,460
6,467
24,617
47,095
Capital Expenditure
-1,191
-1,191
-1,027
-1,974
-819
Issuance of Capital Stock
23,321
23,321
810
48
42,285
Issuance of Debt
13,843
13,843
29,976
3,308
18,706
Repayment of Debt
-8,767
-8,767
-24,148
-2,307
-9,265
Repurchase of Capital Stock
-25
-25
--
-192
--
Free Cash Flow
-13,113
-13,113
-22,032
-23,336
-12,953
3/31/2021 - 1/5/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NTBLQ Notable Labs, Ltd.
0.0001
0.00%
RFM.MU Sensorion SA
0.6120
0.00%
6IV.BE Inventiva SA
2.7400
-1.26%
AAVXF ABIVAX Société Anonyme
5.89
0.00%
ETBI Eastgate Biotech Corp.
0.0045
+4,400.01%
ATHXQ Athersys, Inc.
0.0000
0.00%
ABVX.PA ABIVAX Société Anonyme
6.82
-1.16%
RAPP Rapport Therapeutics, Inc.
7.15
-28.71%
HOPHF Hemogenyx Pharmaceuticals Plc
1.2400
0.00%
IVA.PA Inventiva S.A.
2.8150
+0.91%